|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
|
|---|---|---|---|
| ASSETS | |||
| Current Assets | |||
| Cash and cash equivalents | |||
| Accounts receivable, net | |||
| Due from related parties | |||
| Other current receivables and prepayments | |||
| Total Current Assets | |||
| Non-Current Assets | |||
| Intangible assets, net | |||
| Total Non-Current Assets | |||
| Total Assets | |||
| Current Liabilities | |||
| Accounts payable and accrued expenses | |||
| Bank overdraft | |||
| Accounts payable-related party | |||
| Other payables | |||
| Due to related parties | |||
| Taxes payable | |||
| Total Current Liabilities | |||
| Non-Current Liabilities | |||
| Total Liabilities | |||
| Commitments and Contingencies | |||
| Series B Preferred stock, par value $0.001 per share; 118,000,000 shares authorized; 0 shares issued and outstanding at June 30, 2026 and December 31, 2025 | |||
| Common Stock, par value $0.001 per share; 40,000,000,000 shares authorized; 40,388,706 shares issued and outstanding at June 30, 2026 and December 31, 2025 | |||
| Additional paid-in capital | |||
| Accumulated loss | |||
| Accumulated other comprehensive loss | |||
| Total Shareholders’ Equity | |||
| Total Liabilities and Shareholders’ Equity |
Loading...
